Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines

Molecular and Cellular Endocrinology

Volumn 327, Issue 1-2, 2010, Pages 19-24

  Migliaccio, Antimo ^a   Castoria, Gabriella ^a   Giovannelli, Pia ^a   Auricchio, Ferdinando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cross talk; EGF; EGF R; Src dependent signaling pathway; Steroid receptors

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE RECEPTOR B; PROTEIN P85; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; STEROID HORMONE; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

AUTOCRINE EFFECT; BREAST CANCER; CELL MIGRATION; CELL PROLIFERATION; DRUG TARGETING; ENZYME PHOSPHORYLATION; HORMONE BINDING; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; CELL NUCLEUS; DNA; HUMANS; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, STEROID; SRC-FAMILY KINASES;

EID: 77955428685     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.06.014     Document Type: Review

References (41)

1. Arnold S.F., Obourn J.D., Jaffe H., Notides A.C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol. Endocrinol. 1995, 9:24-33.
2. Britton D.J., Scott G.K., Schilling B., Atsriku C., Held J.M., Gibson B.W., Benz C.C., Baldwin M.A. A novel serine phosphorylation site detected in the N-terminal domain of estrogen receptor isolated from human breast cancer cells. J. Am. Soc. Mass Spectrom. 2008, 19:729-740.
3. Cabodi S., Moro L., Baj G., Smeriglio M., Di Stefano P., Gippone S., Surico N., Silengo L., Turco E., Tarone G., Defilippi P. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell. Sci. 2004, 117:1603-1611.
4. Campbell R.A., Bhat-Nakshatri P., Patel N.M., Constantinidou D., Ali S., Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 2001, 276:9817-9824.
5. Castoria G., Lombardi M., Barone M.V., Bilancio A., Di Domenico M., Bottero D., Vitale F., Migliaccio A., Auricchio F. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell. Biol. 2003, 161:547-556.
6. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of estradiol-stimulated MCF-7 cells. EMBO J. 2001, 20:6050-6059.
7. Castoria G., Migliaccio A., Di Domenico M., Lombardi M., de Falco A., Varricchio L., Bilancio A., Barone M.V., Auricchio F. Role of atypical PKC in estradiol-triggered G1/S progression of MCF-7 cells. Mol. Cell. Biol. 2004, 24:7643-7653.
8. Cato A.C., Nestl A., Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci. STKE 2002, 138:RE9.
9. Chung Y.L., Sheu M.L., Yang S.C., Lin C.H., Yen S.H. Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer. Int. J. Cancer 2002, 97:306-312.
10. Di Domenico M., Castoria G., Bilancio A., Migliaccio A., Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res. 1996, 56:4516-4521.
11. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
12. Font de Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 2000, 20:5041-5047.
13. Fox E.M., Andrade J., Shupnik M.A. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 2009, 74:622-627.
14. Giretti M.S., Fu X.D., De Rosa G., Sarotto I., Baldacci C., Garibaldi S., Mannella P., Biglia N., Sismondi P., Genazzani A.R., Simoncini T. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS One 2008, 3:e2238.
15. Hewitt S.C., Harrell J.C., Korach K.S. Lessons in estrogen biology from knockout and transgenic animals. Annu. Rev. Physiol. 2005, 67:285-308.
16. Hurtado A., Holmes K.A., Geistlinger T.R., Hutcheson I.R., Nicholson R.I., Brown M., Jiang J., Howat W.J., Ali S., Caroll J.S. Regulation of Erb-B2 by oestrogen receptor-PAX determines response to tamoxifen. Nature 2008, 456:663-666.
17. Ignar-Trowbridge D.M., Nelson K.G., Bidwell M.C., Curtis S.W., Washburn T.F., McLachlan J.A., Korach K.S. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4658-4662.
18. Imamov O., Lopatkin N.A., Gustafsson J.A. Estrogen receptor beta in prostate cancer. N. Engl. J. Med. 2004, 351:2773-2774.
19. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494.
20. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., Han K., Di Gregorio G.B., Katzenellenbogen J.A., Katzenellenbogen B.S., Roberson P.K., Weinstein R.S., Jilka R.L., Manolagas S.C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001, 104:719-730.
21. Le Romancer M., Treilleux I., Leconte N., Robein-Lespinasse Y., Sentis S., Bouchekioua-Bouzaghou K., Goddard S., Gobert-Gosse S., Corbo L. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol. Cell. 2008, 31:212-221.
22. Levin E.R. Integration of the extra nuclear and nuclear actions of estrogen. Mol. Endocrinol. 2005, 19:1951-1959.
23. Levin E.R. Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2009, 20:477-482.
24. Márquez D.C., Lee J., Lin T., Pietras R.J. Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocrine 2001, 16:73-81.
25. Migliaccio A., Di Domenico M., Castoria G., Nanayakkara M., Lombardi M., de Falco A., Bilancio A., Varricchio L., Ciociola A., Auricchio F. Steroid receptor regulation of EGF signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res. 2005, 65:10585-10593.
26. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., Barone M.V., Ametrano D., Zannini M.S., Abbondanza C., Auricchio F. Steroid-induced androgen receptor-oestradiol receptor-beta Src complex triggers prostate cancer cell proliferation. EMBO J. 2000, 19:5406-5417.
27. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., Gong W., Beato M., Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 1998, 17:2008-2018.
28. Migliaccio A., Varricchio L., de Falco A., Castoria G., Arra C., Yamaguchi H., Ciociola A., Lombardi M., Di Stasio R., Barbieri A., Baldi A., Barone M.V., Appella E., Auricchio F. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 2007, 26:6619-6629.
29. O'Malley B.W. A life-long search for the molecular pathways of steroid hormone action. Mol. Endocrinol. 2005, 19:1402-1411.
30. Pawson T. Dynamic control of signaling by modular adaptor proteins. Curr. Opin. Cell. Biol. 2007, 19:112-116.
31. Pietras R.J., Arboleda J., Reese D.M., Wongvipat N., Pegram M.D., Ramos L., Gorman C.M., Parker M.G., Sliwkowski M.X., Slamon D.J. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 1995, 15:2435-2446.
32. Razandi M., Pedram A., Park S.T., Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 2003, 278:2701-2712.
33. Rayala S.K., Talukder A.H., Balasenthil S., Tharakan R., Barnes C.J., Wang R.A., Aldaz M., Khan S., Kumar R. P21-activated kinase1 regulation of estrogen receptor-activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res. 2006, 66:1694-1701.
34. Schiff R., Massarweh S., Shou J., Osborne C.K. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin. Cancer Res. 2003, 9:447s-454s.
35. Shou J., Massarweh S., Osborne C.K., Wakeling A.E., Ali S., Weiss H., Schiff R. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J. Natl. Cancer. Inst. 2004, 96:926-935.
36. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000, 407:538-541.
37. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., Press M.F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712.
38. Song R., Barnes C., Zhang Z., Bao Y., Kumar R., Santen R. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2076-2081.
39. Varricchio L., Migliaccio A., Castoria G., Yamaguchi H., de Falco A., Di Domenico M., Giovannelli P., Farrar W., Appella E., Auricchio F. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor {alpha} tyrosine-phosphorylated peptide. Mol. Cancer Res. 2007, 11:1213-1221.
40. Vignon F., Bouton M.M., Rochefort H. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem. Biophys. Res. Commun. 1987, 146:1502-1508.
41. Vivacqua A., Lappano R., De Marco P., Sisci D., Aquila S., De Amicis F., Fuqua S.A., Andò S., Maggiolini M. G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. Mol. Endocrinol. 2009, 23:1815-1826.